Category : Clinical Intelligence/Clinical Efficiency

Proceeds to Fund Development of Novel RNAi Therapeutics for Cancers, Viral Infections, Fibrosis, and Metabolic Diseases Sirnaomics Ltd., a leading biopharmaceutical company in discovery and development...

Norwegian radiopharmaceutical company announces successful closing of a private placement that will allow the company to initiate the next phase of clinical development of its...

Lyndra Therapeutics, a clinical-stage biotechnology company pioneering a novel technology platform that transforms daily pills into once-weekly to monthly oral treatment options, today announced the...

Agreement provides NCCA sites access to VIPER™ and other Deep Lens services to improve clinical trial recruitment efficiency Partnership will also expand clinical trial offering to...

Nucleai (www.nucleaimd.com), a precision medicine company using AI-powered image analysis technology to support novel pathology-based biomarker development, and Merck KGaA, Darmstadt, Germany, a leading science...

Longwood Fund-founded company has raised over $70 million since its Q4 2020 launch Proprietary platform licensed from Dr. Stephen Elledge’s laboratory used to develop novel...

Support from a consortium of leading healthcare investors and Change Healthcare will enable the company to grow platform to streamline and automate clinical research processes...

Financing round led by Advantech healthcare investment team Funds will support Phase 3 program for pegsitacianine and IND-enabling activities for ONM-501 OncoNano Medicine, Inc. today announced...

Proceeds to support rapid advancement of pipeline with over 15 therapeutic programs currently in development across oncology, major inflammatory disorders and rare disease Company to...

Series B financing co-led by SoftBank Vision Fund 2 and Cormorant Asset Management Financing accelerates development of Umoja’s pipeline of in vivo engineered CAR T...